302) Further prospective studies should be designed to elucidate th |
303) re benefit in selected cases, but further studies should be required to clearly demo |
304) Adequately powered studies should explore the potential benef |
305) Future studies should focus on broader clinical v |
306) Future studies should focus on testing other psyc |
307) Future studies should investigate specific calibr |
308) Future studies should prioritize the alpha taxono |
309) of parameter estimates obtained in other studies is given, pointing to a considerab |
310) ation in large population-based or cohort studies is needed. |
311) Further research with supporting clinical studies is required to identify the most e |
312) A limitation of these studies is that associations between these |
313) A problem for such studies is that designs with an optimal ef |
314) The challenge encountered in these studies is the non-identifiability because |
315) In many studies we wish to assess how a range of v |
316) In our previous studies, we confirmed that low-level laser |
317) As in previous studies, we found that predictable in-time |
318) Following promising preclinical studies, we report our first clinical expe |
319) In these studies, we showed that disruption of the |
320) According to the results of these studies, we suggest that tocopherol supple |
321) Studies suggest we capitalize upon religio |
322) Recent studies suggest that bone marrow (BM)-deri |
323) Our studies suggest that the cholinergic and n |
324) In particular, these studies suggest that the surrounding tissu |
325) oked by health care providers, yet recent studies suggest there is an association be |
326) Our work also studies the tradeoff between economic bene |
327) Based on ultrastructural studies, the authors demonstrate the prese |
328) The discussion focuses on two case studies, the first of which examines the u |
329) Based on ex vivo permeation studies, the formulation consisting of car |
330) Our main finding is that across all studies, the observed overall probability |
331) Evidence from human studies as well as animal models have show |
332) lds including epidemiological and medical studies as well as financial and sociologi |
333) tive, retrospective, and laboratory-based studies as well as reviews. |
334) er Neutral Physical Performance Standards studies, as well as the reimplementation o |
|